Stock Information

• Lexicon Pharmaceuticals, Inc. (LXRX) Q1 2026 Earnings Call Transcript
  Thu, May 7, 2026 5:11 PM
• Transcript : Lexicon Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 07, 2026
  Thu, May 7, 2026 5:05 PM
• Lexicon Pharmaceuticals (LXRX) Reports Break-Even Earnings for Q1
  Thu, May 7, 2026 12:50 PM
• Lexicon Pharmaceuticals (NASDAQ:LXRX) Q1 2026 Results Show Revenue Beat and Narrowed Loss
  Thu, May 7, 2026 12:32 PM
• Lexicon Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Clinical Updates
  Thu, May 7, 2026 11:30 AM
• Lexicon: Q1 Earnings Snapshot
  Thu, May 7, 2026 7:48 AM
• Lexicon Pharmaceuticals Q1 Sales $1.090M Miss $9.380M Estimate
  Thu, May 7, 2026 7:31 AM
• Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital
  Mon, May 4, 2026 8:05 PM
• Novo Nordisk Extends Pipeline With Semaglutide Alcohol Study And LX9851 Trial
  Sun, May 3, 2026 11:08 PM
• Lexicon Pharma (LXRX), Novo Nordisk (NVO) Initiate Phase 1 Study for Obesity Drug LX9851
  Fri, May 1, 2026 9:23 AM

Financial data not available